Uncategorized

Celldex, Geron, Halozyme, Lexicon, and Synergy look like good small-cap biotech stocks for investors not afraid to take on risk. Looking to add a few thrills to your investing portfolio?

These household brands, and one under-the-radar company, are the hallmarks of dividend consistency. Dividends stocks are the heart and soul of most retirement portfolios. Historically, dividend stocks have handily outperformed

Is it just a number, or does cracking through a milestone mean something for the market? The Dow Jones Industrial Average(DJINDICES:$INDU) is over 20,000! The media is lauding this feat, but should investors

With unit revenue comparisons about to get a lot easier and plenty of profit growth initiatives in the works, JetBlue could be a great stock to own in 2017. After

Just south of Key Biscayne’s tip, there’s a group of houses precariously perched on stilts dug into the sand banks of Biscayne Bay. As early as the 1920s, long before

Confused about retirement planning? Here’s how to get started this year. Saving for retirement is a challenge many workers face, but without an amply funded nest egg, you risk running

This healthcare real estate company pays a massive dividend, but is it safe? Healthcare real estate investment trust Senior Housing Properties Trust (NASDAQ:SNH)pays a dividend yield of 8.2%. Generally, when a dividend

Despite a 21.5% rise in six months, this analyst is still betting on Apple stock — for three key reasons. Apple (NASDAQ:AAPL) stock has been on quite the tear recently, rising 21.5%

The reasons these solid companies are undervalued today are as varied as their business models, but they have one thing in common: enormous opportunities. If one of your resolutions for

Here are five ways to boost the investment performance of your retirement savings and end up with tens of thousands, or hundreds of thousands of dollars more in retirement. Your

This company is about so much more than just search, and that should get you excited. Saying that you’re going to buy a stock and never sell it seems a bit audacious.

Peter Lynch’s stock-picking acumen is legendary, and our top contributors think that if he were running Fidelity Magellan today, he might consider owning these stocks. Perhaps the most well-known portfolio